Generic Pharmaceutical Manufacturing Company
Panacea Biotec ▸ Facts ▸ Comments ▸ News ▸ Videos
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker registered in India with principal offices in New Delhi, Mumbai, and Lalru. Panacea Drugs Pvt. Ltd. was set up in the year 1984 and got listed in 1995 as Panacea Biotec Ltd. The company has grown organically to become one of the largest vaccine manufacturers in India. It has strong roots in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Russian Direct Investment Fund (RDIF) collaborated with Panacea Biotec to produce 'Sputnik V' Covid-19 vaccine in India.
You Might Like
Panacea Biotec supplies second component of Sputnik V vaccine in India
Covid: One-dose Sputnik Light set for rollout in SeptemberIndia’s immunisation plan against Covid-19 may get bolstered soon with the rollout of locally manufactured single-dose Sputnik Light in September. Panacea Biotec, which had earlier partnered Russian..
Panacea Biotec to manufacture up to 25 million doses of Sputnik V vaccineThe company has entered into a "licensing and manufacturing agreement with Human Vaccine Limited Liability Company, a subsidiary of Russian Direct Investment Fund, Russia, Generium Joint Stock..
Sputnik V vaccine production in India to go fully on stream in September: RDIFThe production of Sputnik V in India is expected to come fully on stream in September. "Production in India is expected to come fully onstream in September and RDIF expects India to become a major..
COVID-19: Panacea Biotec, RDIF to start Sputnik V production in IndiaRDIF and Panacea have agreed to produce 100 million doses per year of Sputnik V.
Seven Indian pharma players race to develop Covid-19 vaccineAt least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already..
Indian firm Panacea says aiming to make COVID-19 vaccineIndian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with U.S.-based Refana Inc to make a potential vaccine for COVID-19.